Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from MIRA Pharmaceuticals, Inc. ( (MIRA) ) is now available.
MIRA Pharmaceuticals, Inc. announced changes in its executive team with the resignation of Michelle Yanez as Chief Financial Officer, Treasurer, and Secretary, effective May 16, 2025. The company appointed Alan Weichselbaum as the new Chief Financial Officer, effective May 15, 2025. Mr. Weichselbaum brings over 30 years of experience in corporate finance and strategic advisory, which is expected to bolster MIRA Pharmaceuticals’ growth through drug development and potential M&A opportunities.
The most recent analyst rating on (MIRA) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on MIRA Pharmaceuticals, Inc. stock, see the MIRA Stock Forecast page.
More about MIRA Pharmaceuticals, Inc.
Average Trading Volume: 1,323,016
Technical Sentiment Signal: Buy
Find detailed analytics on MIRA stock on TipRanks’ Stock Analysis page.